The unit that ran the gene therapy trial during which 18-year-old Jesse
Gelsinger died last year will no longer carry out clinical studies. The
University of Pennsylvania in Philadelphia announced last week that its
Institute for Human Gene Therapy, directed by James Wilson, will now concentrate
on basic research. The decision comes as a serious blow to an institute that
once led the world in moving gene therapy from the lab to the clinic. Wilson
said in a statement that the institute would develop 鈥渁 foundation of science
necessary to assure the ultimate success of this field.鈥�
More from New 女生小视频
Explore the latest news, articles and features
Health
Personalised cancer vaccine expected to be approved next year
News
Technology
Brazil presidential election dogged by alleged bias by Meta AI tools
News
Health
Body temperature may drive the higher risk of autoimmune conditions in women
News
Comment
Emily St. John Mandel: ‘I don’t want to write something relentlessly bleak’
Culture
Popular articles
Trending New 女生小视频 articles